Algernon Pharmaceuticals Inc (AGNPF)

[tcm7]

Setting up the Multinational 2b/3 Clinical Trials with help thru CRO NOVOTECH. USFDA next, MULTINATIONAL, get it.?.

In addition to Australia, the Company is also planning to conduct the multinational phase 2b/3 clinical study in Canada and the U.S. Algernon has already received clearance for the clinical study in Canada and is preparing to file an investigational new drug (IND) application with the U.S. FDA.

“Thanks to the hard work of our CRO partner Novotech, this ethics submission is yet another important step in the Company’s COVID-19 clinical development program,” said Christopher J. Moreau, CEO of Algernon Pharmaceuticals Inc. “The Algernon team is working hard to finalize the U.S. FDA IND application and will be updating the market on its progress shortly.”